APA (7th ed.) Citation

Lontos, K., Tsagianni, A., Agha, M., Raptis, A., Hou, J., Farah, R., . . . Boyiadzis, M. (2022). A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Leukemia & Lymphoma, 63(13), 3257. https://doi.org/10.1080/10428194.2022.2118532

Chicago Style (17th ed.) Citation

Lontos, Konstantinos, et al. "A Nomogram Using Cytogenetics, TP53, and NPM1 Mutational Status Can Predict Responses to Induction Chemotherapy in AML." Leukemia & Lymphoma 63, no. 13 (2022): 3257. https://doi.org/10.1080/10428194.2022.2118532.

MLA (9th ed.) Citation

Lontos, Konstantinos, et al. "A Nomogram Using Cytogenetics, TP53, and NPM1 Mutational Status Can Predict Responses to Induction Chemotherapy in AML." Leukemia & Lymphoma, vol. 63, no. 13, 2022, p. 3257, https://doi.org/10.1080/10428194.2022.2118532.